Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinuko Mitani

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Cancer Science|June 26, 2023
Clinical and prognostic features of Langerhans cell histiocytosis in adultsAki Sato, Masayuki Kobayashi, Nozomi Yusa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donorsYukiko Komeno, Yoshinobu Kanda, Tamae Hamaki, et al.
International Journal of Hematology|January 3, 2024
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional studyDaisuke Minakata, Tomoyuki Uchida, Aya Nakano, et al.
Leukemia Research|July 2, 2013
CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21)Noriyoshi Iriyama, Yoshihiro Hatta, Jin Takeuchi, et al.
International Journal of Hematology|July 13, 2022
ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trialYasuyoshi Morita, Yasuhito Nannya, Motoshi Ichikawa, et al.
British Journal of Haematology|February 2, 2013
Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemiaShinichi Kako, Heiwa Kanamori, Naoki Kobayashi, et al.
Transplantation|February 9, 2005
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host diseaseAkiko Hori, Yoshinobu Kanda, Susumu Goyama, et al.
Transfusion|July 21, 2021
Allo-anti-M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusionYoshiko Tamai, Hitoshi Ohto, Hiroyasu Yasuda, et al.
British Journal of Haematology|July 10, 2025
Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 studyJong Wook Lee, Jun Ho Jang, Shigeru Chiba, et al.
Haematologica|July 7, 2018
Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in JapanNaoto Takahashi, Kaichi Nishiwaki, Chiaki Nakaseko, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Cancer Science|June 26, 2023
Clinical and prognostic features of Langerhans cell histiocytosis in adultsAki Sato, Masayuki Kobayashi, Nozomi Yusa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donorsYukiko Komeno, Yoshinobu Kanda, Tamae Hamaki, et al.
International Journal of Hematology|January 3, 2024
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional studyDaisuke Minakata, Tomoyuki Uchida, Aya Nakano, et al.
Leukemia Research|July 2, 2013
CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21)Noriyoshi Iriyama, Yoshihiro Hatta, Jin Takeuchi, et al.
International Journal of Hematology|July 13, 2022
ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trialYasuyoshi Morita, Yasuhito Nannya, Motoshi Ichikawa, et al.
British Journal of Haematology|February 2, 2013
Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemiaShinichi Kako, Heiwa Kanamori, Naoki Kobayashi, et al.
Transplantation|February 9, 2005
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host diseaseAkiko Hori, Yoshinobu Kanda, Susumu Goyama, et al.
Transfusion|July 21, 2021
Allo-anti-M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusionYoshiko Tamai, Hitoshi Ohto, Hiroyasu Yasuda, et al.
British Journal of Haematology|July 10, 2025
Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 studyJong Wook Lee, Jun Ho Jang, Shigeru Chiba, et al.
Haematologica|July 7, 2018
Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in JapanNaoto Takahashi, Kaichi Nishiwaki, Chiaki Nakaseko, et al.
Pageof 15